INTERNATIONAL IGAN PREDICTION TOOL POST-BIOPSY - PEDIATRICS

This model can be used at a time point up to 2-years after biopsy in children with IgA nephropathy to predict the subsequent risk of a 30% decline in eGFR or ESKD.

0% Complete
0%

Question 1 of 16

1. Age at landmark time post biopsy?

Years

Pick a fixed landmark time for risk stratification as either 1 or 2 years post-biopsy and use the same landmark time for all variables entered in this model.

Minimum value is 1.

QUESTION REVIEW

1. Age at landmark time post biopsy?
Answer
2. Sex?
Answer
3. Height at the landmark time post biopsy? (optional - if not available, age-based formula will be used for eGFR)
Optional
4. Weight at the landmark time post biopsy?
Answer
5. Proteinuria at landmark time post biopsy
Answer
6. Serum Creatinine at landmark time post-biopsy?
Answer
7. Systolic blood pressure at the landmark time post biopsy?
Answer
8. Diastolic blood pressure at the landmark time post biopsy?
Answer
9. Ethnicity
Answer
10. Use of ACE inhibitor or ARB at the landmark time post biopsy?
Answer
11. MEST M-score
Answer
12. MEST E-score
Answer
13. MEST S-score
Answer
14. MEST T-score
Answer
15. Immunosuppression use at or prior to biopsy
Answer
16. At how many months after the landmark time post biopsy would you like to determine risk of renal progression?
Answer